期刊文献+

慢性低O_2高CO_2肺动脉高压大鼠肺动脉尾加压素Ⅱ受体的动态变化 被引量:6

DYNAMIC CHANGES OF UROTENSIN Ⅱ RECEPTOR IN PULMONARY ARTERY AND ARTERIOLES OF RATS CHRONICALLY EXPOSED TO HYPOXIAHYPERCAPNIA
在线阅读 下载PDF
导出
摘要 目的:探讨尾加压素Ⅱ受体(urotensinⅡreceptor,UT)在慢性低氧高二氧化碳肺动脉高压大鼠肺动脉中的动态变化及其意义。方法:对不同低氧(高二氧化碳)时间(1周、2周、4周)大鼠,放射性配基结合法检测肺动脉质膜UT结合位点,组织原位杂交测定各级肺小动脉UT及尾加压素Ⅱ(UⅡ)mRNA的表达。结果:①肺动脉平均压(mPAP)、右心室(RV)和左心室加室间隔(LV+S)的重量比:1周组(1HH)较对照组(NC)分别增高26.2%和21.6%、2周组(2HH)较1HH增高22.5%和14.1%、4HH组与2HH组间无显著差别(P>0.05)。②肺主动脉质膜UT最大结合位点(Bmax),1HH组比NC组高38.8%(P<0.01),2HH组比1HH组高23.2%(P<0.01),4HH组比2HH组高7.3%(P<0.05),随低氧时间延长有渐升的趋势;UⅡ受体亲和力(Kd值)各组间无差别。③三级肺小动脉UⅡmRNA相对含量的变化:2HH、4HH组明显高于NC组(P均<0.01);2HH组较1HH组分别高5.9%(P>0.05)、16.4%和9.1%(P均<0.01);4HH组与2HH组间无明显差异。④三级肺小动脉UT mRNA相对含量的变化:各低氧高二氧化碳组均高于NC组(P均<0.01),以1HH组后2级肺小动脉的表达最强,而4HH组与2HH组间无显著差别(P>0.05)。⑤肺小动脉显微结构的变化:4HH组各级血管均有显著重构,1HH组无明显变化,2HH组介于两者之间。结论:UT在慢性低氧高二氧化碳肺动脉高压大鼠肺动脉内的动态变化与肺动脉高压、肺血管改建的病理进程密切相关。 Aim:To investigate the dynamic changes and functions of urotensin Ⅱ (UⅡ ) receptor(UT) in pulmonary arteries of rats chronically exposed to hypoxia-hypercapnia. Methods: In rats with hypoxia-hypercapnia at 1,2 and 4 weeks UⅡ receptor binding of pulmonary arteries sarcolemma was determined by radiollgand assay. UⅡ mRNA and UTmRNA in various grades of pulmonary arterioles were measured by in situ hybridization. Results: ① Mean pulmonary pressure (mPAP) and weight ratio of right ventricle to left ventricle and septum( RV/LV + S) of 1-week group were higher than those of normal control (NC) group by 26.2 % and 21.6 % ( P〈0.01), respectively, and 2-week group higher than 1-week group by 22.5% and 14.1% (respectively, P〈0.01). However, no significant changes were found between 4-week and 2-week group. ②UⅡ receptor (Bmax) of 1-week group was higher than NC group by 38.8% , 2-week group higher them 1-week group by 23.2%,and 4-week group increased 7.3 % compared with 2-week group( respectively, P 〈 0.01 ). The UT changes were time-dependent, while the affinity to U Ⅱ (Kd) was no different among each group. ③ UⅡ mRNA in each grade of pulmonary arterioles of 2-week group and 4 week group were higher than NC group(respectively, P〈0.01), and those of 2 week group were higher than 1-week group by 5.9%(P〉0.05), 16.4% and 9.1%(respectively, P〈 0.01 ), while no differences existed between 2-week group and 4 week group. ④ UT mRNA in each grade of pulmonary arterioles of all hypoxia-hypercapnia groups was higher than NC group (respectively, P〈 0.01 ), and those of two abaxial grade vessels in 1-week group were the highest. No differences existed between 2-week group and 4-week group. ⑤The pulmonary vessels remodeling were time-dependently aggravated by hypoxia-hypercapnia. Conclusion: The dynamic changes of UT in pulmonary arterioles might have important contribution to the development of pulmonary hypertension and pulmonary arteriole remo-deling induced by chronic hypoxia-hypercapnia in rats.
出处 《中国应用生理学杂志》 CAS CSCD 北大核心 2005年第4期377-381,共5页 Chinese Journal of Applied Physiology
基金 浙江省教育厅科研基金资助项目(20020468) 温州市科委基金资助项目(Y2003A037)
关键词 尾加压素 受体 低氧 高血压 肺性 urotensin receptor hypoxia hypertension, pulmonary
  • 相关文献

参考文献9

  • 1Ames R S, Sarau H M, Chambers J K, et al. Human urotensin-Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPR14[J]. Nature, 1999, 401(6750) : 282-286.
  • 2胡良冈,龚永生,范小芳,李继武,郑绿珍.常压低氧高二氧化碳清洁级动物饲养舱的研制[J].医疗卫生装备,2003,24(4):16-17. 被引量:27
  • 3Itoh H, McMaster D, Lederis K. Functional receptors for fish neuropeptide urotensin Ⅱ in major rat arteries[J]. Eur J Pharmacol, 1988, 149(1-2): 61-66.
  • 4Douglas S A, Tayara L, Ohlstein E H, et al. Congestive heart failure and expression of myocardial urotensinⅡ[J]. Lancet, 2002, 359(9322). 1990-1997.
  • 5Gendron G, Gobeil F Jr, Morin J, et al. Contractile responses of aortae from WKY and SHR to vasoconstrietors[J]. Clin Exp Hypertens, 2004, 26(6) : 511-523.
  • 6Kompa A R, Thoma W G, See F, et al. Cardiovascular role of urotensin Ⅱ: effect of chronic infusion in th erat[J]. Peptides, 2004, 25(10): 1783-1788.
  • 7Qi J, Du J, Tang X, et al. The upregulation of endothelial nitric oxide synthase and urotensin-Ⅱ is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting[J]. Heart Vessels, 2004, 19(2): 81-88.
  • 8Johns D G, Ao Z, Naselsky D, et al. Urotensin-Ⅱ-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators [ J ].Naunyn Schmiedebergs Arch Pharmacol, 2004, 370(4) : 238-250.
  • 9龚永生,胡良冈,范小芳,李继武,郑绿珍,陈少贤,唐朝枢,庞永正.慢性低氧对大鼠血浆尾加压素Ⅱ浓度和右心室尾加压素Ⅱ受体的影响[J].中国病理生理杂志,2003,19(5):704-705. 被引量:8

二级参考文献7

  • 1Coulouam Y, Lihrman I, Jegou S, et al. Cloning of cDNA encoding the urotensin Ⅱ precursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord [J] .Proc Natl Acad Sci USA, 1998,95(26):15803- 15808.
  • 2Ames RS,Sarau HM, Chambels JK, et al. Human Urotensin-Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPRl4[J]. Nature, 1999,401(6750) :282- 286.
  • 3MacLean MR, Alexander D, Stirrat A, et al. Contractile responses to human urotensin - H in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat [J]. Br J Pharmal,2000,130(2) :201 - 204.
  • 4Wolff AA, Hines DK, Karliner JS. Refined membrane preparations mask ischemic fall in myocardial beta- receptor density[J]. Am J Physiol, 1989,257(3pt2):H1032- H1036.
  • 5Opgaard OS, Nothacker HP, Ehlert FJ, et al. Human urotensin-Ⅱ mediates vasoconstriction via an increase in inosital phosphates [J]. Eur J Pharmacol, 2000,406(2):265- 271.
  • 6胡良冈,武宗寅,龚永生,郑绿珍,王卫.低氧高二氧化碳动物饲养仓的研制[J].医疗卫生装备,1997,18(1):8-10. 被引量:17
  • 7张勇刚,杨军,王晓红,符民桂,张英,唐朝枢.心肌肥大大鼠心肌尾加压素II受体的变化[J].中国病理生理杂志,2001,17(3):204-206. 被引量:14

共引文献30

同被引文献52

  • 1刘伯英,于忠和,郝淑玲.低氧大鼠血浆和支气管肺泡灌洗液尾加压素Ⅱ的变化[J].第三军医大学学报,2004,26(19):1742-1744. 被引量:16
  • 2张文莉,王士雯,徐斌,黄丽洁,苟鹏,高磊,李泱,高伟.中国小型猪阻塞型睡眠呼吸暂停模型的建立[J].中国比较医学杂志,2004,14(5):286-289. 被引量:22
  • 3张珺辉,张靖溥.尾加压素II与支气管哮喘相关性的研究[J].中国临床医学,2004,11(6):971-973. 被引量:3
  • 4王璋,司良毅,廖友斌.大鼠睡眠呼吸暂停综合征动物模型的建立[J].中国实验动物学报,2006,14(1):40-43. 被引量:39
  • 5陈华 李春海 贺苏兰 等.SPF、清洁级普通大鼠部分生物学特性比较.实验动物科学与管理,1998,15(3):57-57.
  • 6Netzer NC,Hoegel JJ,Loube D,et al.Prevalence of symptoms and risk of sleep apnen in primary care[J].Chest,2003,124(4):1406-1414.
  • 7Winbond Electronic Corp.W78E516B 8-bit microcontroller.Winbond Microcontroller Datasheet.Publication Release Data:December 4,2006.Revision A11:1-37.
  • 8Kimoff RJ,Makino H,Horner RL,et al.Canine model of obatructive sleep apnea:model description and preliminary application[J].J Appl Physiol,1994,76:1810-1817.
  • 9Hendricks JC,Kline LR,Kovalski R J,et al.The English bulldog a natural model of sleep-disordered breathing[J].J Appl Physiol 1987,63(4):1344-1350.
  • 10Schneider H,Schaub,CD,Chen,CA,et al.Neural and local effects of hypoxia on cardiovascular responses to obstructive apnea[J].J Appl Physiol,2000,88(3):1093-1102.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部